Skip to main content
Menu

AlphaLISA SureFire Biotin-Free Human and Mouse Androgen Receptor Full-length Specific Detection Kit, 500 Assay Points

The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Androgen Receptor Full-length Specific assay is a sandwich immunoassay for quantitative detection of androgen receptor full-length specific in cellular lysates using Alpha Technology.

Feature Specification
Application Cell Signaling
Protocol Time 2h at RT
Sample Volume 10 µL

The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Androgen Receptor Full-length Specific assay is a sandwich immunoassay for quantitative detection of androgen receptor full-length specific in cellular lysates using Alpha Technology.

Product variants
Compare all
Remove all
Add to compare Add to compare
Remove
Unit Size: 100 Assay Points
Part #:
ASBF-TARFLS-A-HV
List price
USD 737.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 500 Assay Points
Part #:
ASBF-TARFLS-A500
List price
USD 2,490.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 10,000 Assay Points
Part #:
ASBF-TARFLS-A10K
List price
USD 14,982.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 50,000 Assay Points
Part #:
ASBF-TARFLS-A50K
List price
USD 47,624.00
Your price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Loading...

Overview

The full-length androgen receptor (AR-FL) represents the canonical, ligand-dependent form of AR comprising all functional domains: the N-terminal transactivation domain (NTD), DNA-binding domain (DBD), hinge region, and C-terminal ligand-binding domain (LBD). AR-FL requires androgen binding to the LBD for full activation, nuclear translocation, and transcriptional activity, making it the primary target of androgen deprivation therapies and second-generation antiandrogens such as enzalutamide and apalutamide, which competitively inhibit ligand binding. In castration-resistant prostate cancer (CRPC), AR-FL can be aberrantly activated through AR gene amplification, LBD point mutations that broaden ligand specificity, or intratumoral androgen synthesis. AR-FL-specific detection, which distinguishes full-length AR from truncated splice variants lacking the LBD, is essential for accurately characterizing AR signaling status and predicting response to LBD-targeting therapies. Monitoring AR-FL levels in the context of emerging splice variants provides critical insight into mechanisms of therapeutic resistance in prostate cancer.

The AlphaLISA SureFire Biotin-Free Human and Mouse Androgen Receptor Full-length Specific Detection Kit is a sandwich immunoassay for the quantitative detection of androgen receptor full-length in cellular lysates, using Alpha Technology.

Formats:

  • The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
  • The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
  • The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
  • The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Biotin Free kits are compatible with:

  • Cell and tissue lysates
  • Antibody modulators
  • Biotherapeutic antibodies
  • Biotin rich samples

AlphaLISA SureFire Biotin Free kits can be used for:

  • Cellular kinase assays
  • Receptor activation studies
  • High-throughput screening for preclinical studies

How it works

Total-AlphaLISA SureFire Biotin Free assay principle

The Total-AlphaLISA SureFire Biotin Free assay measures the expression level of a target protein in a biological sample (e.g. cell lysate).

The Total-AlphaLISA SureFire Biotin Free assay uses two antibodies which recognize two different distal epitopes on the target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor Beads are coated with a proprietary CaptSure3 agent to capture one of the detection antibodies, which is labeled with the CaptSure3 tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.

Total-AlphaLISA SureFire Ultra Biotin Free assay principle

 

Total-AlphaLISA SureFire Biotin Free two-plate assay protocol

The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Biotin Free detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.

2 plates assay protocol alphalisa surefire ultra biotin free total assay

Total-AlphaLISA SureFire Biotin Free one-plate assay protocol

Detection of Total target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.

1 plate assay protocol alphalisa surefire ultra biotin free total assay

Assay validation

Degradation of AR-FL by ARV-110 PROTAC in a dose dependent manner

LNCaP cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of ARV-110 PROTAC for 18 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). Lysates were further diluted and AR-FL and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays*. For the detection step, 10 µL of cell lysate (approximately 1,200 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, ARV-110 induced a dose dependent decrease in AR-FL with no significant changes ERK Total levels.

*AR-FL Specific assay only recognizes Full Length AR protein.

Pharmacological Validation (Degradation) of AR-FL Specific Total assay

MCF7 cells were seeded in a 96-well plate (40,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of ARV-110 PROTAC for 24 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). AR-FL and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, ARV-110 induced a dose dependent decrease in AR-FL with no significant changes in the levels of ERK Total.

Pharmacological Validation (Degradation) of AR-FL Specific Total assay

Degradation of AR-FL in 22Rv1 cells treated with AR Degrader-8

22Rv1 cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of AR Degrader-8 for 24 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). Lysates were further diluted and AR-FL and ERK Total levels were evaluated using AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 1,200 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, AR Degrader-8 induced a dose-dependent decrease in AR-FL with no change in ERK Total levels.

Pharmacological Validation (Degradation) of AR-FL Specific Total assay

Assay versatility

AR-FL expression in various cell lines

Adherent cells were grown to confluency in a T175 flask in complete medium and lysed with Lysis Buffer at a density of 0.5 x 106 cells/mL. Suspension cells were harvested, spun down and lysed with Lysis Buffer at a density of 1.6 x 106 cells/mL.

AR-FL levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (5,000 adherent and 16,000 suspension cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

AR-FL expression was detected in various cell lines. Elevated levels were observed in LNCaP cells. No expression was detected in PC3 cells (AR negative cell line).

AR-FL Specific Total assay versatility

Assay sensitivity

Assay sensitivity - cell lysate dilution

Cell lysate was prepared from LNCaP cells seeded in T175 flasks and cultured to confluence and lysed in 8 mL of Lysis Buffer for 10 minutes at RT with shaking.

Lysate was serially diluted in Lysis Buffer and AR-FL levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

Approximate number of cells per datapoint is indicated. The dotted line represents assay background. The AR-FL Specific Total assay can detect AR-FL expression in less than 100 cells.

AR-FL Specific Total assay sensitivity

Specifications

Application
Cell Signaling
Automation Compatible
Yes
Brand
AlphaLISA SureFire Biotin-Free
Detection Modality
Alpha
Product Group
Kit
Protocol Time
2h at RT
Sample Volume
10 µL
Shipping Conditions
Shipped in Blue Ice
Target
Androgen
Target Class
Phosphoproteins
Target Species
Human
Mouse
Technology
Alpha
Therapeutic Area
Oncology
Unit Size
500 Assay Points

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Guide Icon
Guide
AlphaLISA SureFire Ultra: the ultimate guide for successful experiments

The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay

Several biological processes are regulated by...

Loading...

Revvity AI Assistant Beta

Scroll Icon